Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Vaccines |
Free Subscription
1 BMJ |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Vaccines is free of charge.
Measles: Birmingham outbreak declared a national incident and likely to spread.
BMJ. 2024;384:q159.
PubMed
Sexual and Gender Minorities' Vaccine Uptake and Behavioral Change in Response to
the Mpox Outbreak in the United States: August 2022 Through November 2022.
Clin Infect Dis. 2024 Jan 23:ciad793. doi: 10.1093.
PubMed
Abstract available
Efficacy and safety of respiratory syncytial virus prefusion F protein vaccine
(RSVPreF3 OA) in older adults over 2 RSV seasons.
Clin Infect Dis. 2024 Jan 22:ciae010. doi: 10.1093.
PubMed
Abstract available
Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and
Immunization Practices (ACVIP): Recommended Immunization Schedule (2023) and
Update on Immunization for Children Aged 0 Through 18 Years.
Indian Pediatr. 2024 Jan 15:S097475591600592.
PubMed
Abstract available
Enhancement of cellular immunity following needle-free vaccination of mice with
SARS-CoV-2 spike protein.
J Gen Virol. 2024;105.
PubMed
Abstract available
A Predictive Model of Vaccine Reactogenicity Using Data from an In Vitro Human
Innate Immunity Assay System.
J Immunol. 2024 Jan 26:ji2300185. doi: 10.4049/jimmunol.2300185.
PubMed
Abstract available
A novel strategy for an anti-idiotype vaccine: nanobody mimicking neutralization
epitope of porcine circovirus type 2.
J Virol. 2024 Jan 25:e0165023. doi: 10.1128/jvi.01650.
PubMed
Abstract available
Individualised neoantigen cancer vaccine therapy.
Lancet. 2024 Jan 18:S0140-6736(23)02463-7. doi: 10.1016/S0140-6736(23)02463.
PubMed
Personalized mRNA vaccine boosts melanoma immunotherapy.
Nat Med. 2024 Jan 25. doi: 10.1038/d41591-024-00006.
PubMed
Modelling disease mitigation at mass gatherings: A case study of COVID-19 at the
2022 FIFA World Cup.
PLoS Comput Biol. 2024;20:e1011018.
PubMed
Abstract available
Cross-sectional survey evaluating the psychological impact of the COVID-19
vaccination campaign in patients with cancer: The VACCINATE study.
PLoS One. 2024;19:e0290792.
PubMed
Abstract available
Interplay between vaccines and treatment for dengue control: An epidemic model.
PLoS One. 2024;19:e0295025.
PubMed
Abstract available
Influence of Community Determinants on Barriers and Facilitators to COVID-19
Vaccine Uptake: Regional Stakeholders' Perspectives.
Vaccine. 2024 Jan 24:S0264-410X(24)00051-3. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Lessons learned: COVID-19 vaccinations and people with disabilities.
Vaccine. 2024 Jan 23:S0264-410X(24)00028-8. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Impact of innovative immunization strategy on PCV13 vaccination coverage among
children under 5 years in Weifang city, China: A retrospective study.
Vaccine. 2024 Jan 23:S0264-410X(24)00030-6. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Can endorsement by religious leaders move the needle on vaccine hesitancy?
Vaccine. 2024 Jan 18:S0264-410X(24)00006-9. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Immunogenicity of tick-borne-encephalitis-virus-(TBEV)-vaccination and impact of
age on humoral and cellular TBEV-specific immune responses in patients with
rheumatoid arthritis.
Vaccine. 2024 Jan 18:S0264-410X(24)00022-7. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Implications of vaccine non-specific effects on licensure of new vaccines.
Vaccine. 2024 Jan 18:S0264-410X(24)00060-4. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Mixed-methods examination of attitudes and behaviors related to COVID-19 vaccines
among parents of children with autism and autistic adults.
Vaccine. 2024 Jan 19:S0264-410X(24)00013-6. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
SARS-CoV-2 vaccination willingness and humoral vaccination response in radiation
oncology patients.
Vaccine. 2024 Jan 20:S0264-410X(24)00004-5. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Incidence rates of myocarditis and pericarditis within 30 days following
homologous and heterologous BNT162b2 vaccinations in individuals 5-40 years of
age.
Vaccine. 2024 Jan 20:S0264-410X(24)00026-4. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Examining changes in sense of purpose before, during, and after COVID-19
vaccination.
Vaccine. 2024 Jan 20:S0264-410X(24)00027-6. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Vaccine-preventable diseases: Immune response in a large population of healthcare
students.
Vaccine. 2024 Jan 20:S0264-410X(24)00049-5. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Boot Camp Translation using Community-Engaged messaging for adolescent
Vaccination: A Cluster-Randomized trial.
Vaccine. 2024 Jan 21:S0264-410X(24)00054-9. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Study of immunogenicity and efficacy against Omicron BA.5 of recombinant
protein-based COVID-19 vaccine delivered by intramuscular and mucosal routes in
nonhuman primates.
Vaccine. 2024 Jan 22:S0264-410X(24)00034-3. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA
vaccination in patients with pediatric rheumatic diseases: A prospective cohort
study.
Vaccine. 2024 Jan 22:S0264-410X(24)00059-8. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
A rabies mRNA vaccine with H270P mutation in its glycoprotein induces strong
cellular and humoral immunity.
Vaccine. 2024 Jan 22:S0264-410X(24)00069-0. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
What would have happened anyway? Population data source considerations when
estimating background incident rates of adverse events following immunisation to
inform vaccine safety.
Vaccine. 2024 Jan 22:S0264-410X(24)00025-2. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Supporting National Immunization Technical Advisory Groups (NITAGs) in
development of evidence-based vaccine recommendations and NITAG assessments - New
tools and approaches.
Vaccine. 2024 Jan 23:S0264-410X(24)00035-5. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Strengthening COVID-19 vaccine confidence & demand during the US COVID-19
emergency response.
Vaccine. 2024 Jan 23:S0264-410X(24)00029-X. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
A phase 3 randomized trial of the safety and immunogenicity of 20-valent
pneumococcal conjugate vaccine in adults?>/=?60 years of age in Japan, South Korea,
and Taiwan.
Vaccine. 2024 Jan 23:S0264-410X(24)00008-2. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
The association between influenza vaccination, cardiovascular mortality and
hospitalization: A living systematic review and prospective meta-analysis.
Vaccine. 2024 Jan 23:S0264-410X(24)00053-7. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Thank you for your interest in scientific medicine.